Platinum
Nov. 2 (Fri), 12:00-13:00
Cosmos Hall (3F)
Seegene is the world's leading developer ofmultiplex molecular technologies and multiplex clinical molecular diagnostics(MDx). Seegene's core enabling technologies - DPO™, TOCE™ and MuDT™ - are the foundation forMDx tests that can simultaneously detect and quantitate multiple targetswith high sensitivity, specificity and reproducibility. Seegene offers MDxtests in infectious diseases, genetics, drug resistance, and oncology, andactively partners in the development of new tests and the improvement of the qualityof healthcare utilizing its breakthrough multiplex molecular technologies.
- One-step process from nucleic acid (NA) extraction to PCR setup - Minimum hands-on time & no manual pipetting - 96 samples processed within 2.5 hrs - Mixed batch testing - Applicable to all types of specimens - Direct loading of primary sample tubes - Applied products: HPV, STI, RV, RP, GI, Thrombosis, TB and more
- Compact and easy to use Real-time PCR instrument - Can be used in various assays - Quantification, Melt analysis, Genotyping - Linkable to Seegene viewer Program for convenient interpretation - Possible to use up to 5 channels - Provides accurate result without cross-talk among wells
- Detect and identifies 16 viruses, 7 bacteria and 3 Flu A subtypes causing respiratory tract infections - Multiplex One-step real-time RT-PCR assay for reliable test results within 4.5 hrs - Individual Ct value of multiple analyte in a single channel of real-time PCR instrument - Flexible choice of target pathogen based panels for efficient patient care and cost-effectiveness - Convenient workflow using Seegene’s automation platform